(NRO) Neurones - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0004050250
NRO: Infrastructure, Application, Consulting, Cybersecurity, Cloud
Neurones S.A. (PA:NRO) is a France-based IT services provider specializing in infrastructure, application, and consulting services. Established in 1984, the company operates both domestically and internationally, catering to diverse industries such as banking/insurance, services/consumer goods, energy/utilities/healthcare, technologies/media/telecoms, industry/public works, and the public sector. Its infrastructure services encompass IT operations management, public and private cloud services, cybersecurity, IT service management, and automation. Application services include SAP, digital solutions, enterprise content management, business process management, robotic process automation (RPA), and IoT innovation. Consulting services focus on digital transformation, agile/scrum methodologies, DevOps, cloud solutions, and digital marketing.
The company’s client-centric approach emphasizes IT consulting, digital transformation, and managed services/outsourcing. Neurones S.A. has built a reputation for integrating cutting-edge technologies like AI, machine learning, and blockchain into its solutions. With a strong foundation in IT service management and a focus on innovation, the company continues to expand its service portfolio to meet evolving market demands.
3-Month Forecast Based on the providedAdditional Sources for NRO Stock
NRO Stock Overview
| Market Cap in USD | 1,307m |
| Sector | Technology |
| Industry | Information Technology Services |
| GiC Sub-Industry | IT Consulting & Other Services |
| IPO / Inception |
NRO Stock Ratings
| Growth Rating | 88.4 |
| Fundamental | 61.3 |
| Dividend Rating | 61.1 |
| Rel. Strength | -5.9 |
| Analysts | - |
| Fair Price Momentum | 53.02 EUR |
| Fair Price DCF | 56.58 EUR |
NRO Dividends
| Dividend Yield 12m | 2.62% |
| Yield on Cost 5y | 7.03% |
| Annual Growth 5y | 43.10% |
| Payout Consistency | 89.2% |
NRO Growth Ratios
| Growth Correlation 3m | -23.9% |
| Growth Correlation 12m | 58.8% |
| Growth Correlation 5y | 96.2% |
| CAGR 5y | 22.03% |
| CAGR/Max DD 5y | 1.03 |
| Sharpe Ratio 12m | -0.17 |
| Alpha | 0.68 |
| Beta | 0.136 |
| Volatility | 21.51% |
| Current Volume | 17.5k |
| Average Volume 20d | 3.8k |
As of May 09, 2025, the stock is trading at EUR 47.20 with a total of 17,472 shares traded.
Over the past week, the price has changed by -1.05%, over one month by +2.61%, over three months by -0.21% and over the past year by +3.72%.
Yes, based on ValueRay Fundamental Analyses, Neurones (PA:NRO) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 61.32 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NRO as of May 2025 is 53.02. This means that NRO is currently undervalued and has a potential upside of +12.33% (Margin of Safety).
Neurones has no consensus analysts rating.
According to ValueRays Forecast Model, NRO Neurones will be worth about 57.3 in May 2026. The stock is currently trading at 47.20. This means that the stock has a potential upside of +21.33%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 60 | 27.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 57.3 | 21.3% |